ArticleFrontiers in chemistry2017
Computational Tool for Fast
Article in Frontiers in chemistry, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
26 citing papers in PubMed, 63 citations in OpenAlex.
- Identification of Novel Drug Molecules Against NS3-Like Helicase Enzyme of Alongshan Virus.Molecular biotechnology · 2025Article
- Synthesis and Evaluation of Thiazolyl-indole-2-carboxamide Derivatives as Potent Multitarget Anticancer Agents.ACS omega · 2024Article
- Enhancing hERG Risk Assessment with Interpretable Classificatory and Regression Models.Chemical research in toxicology · 2024Article
- Using the Correlation Intensity Index to Build a Model of Cardiotoxicity of Piperidine Derivatives.Molecules (Basel, Switzerland) · 2023Article
- Pharmacophoric analogs of sotorasib-entrapped KRAS G12C in its inactive GDP-bound conformation: covalent docking and molecular dynamics investigations.Molecular diversity · 2023Article
- Review
- Integrated virtual screening and molecular dynamics simulation revealed promising drug candidates of p53-MDM2 interaction.Journal of molecular modeling · 2022Article
- In Silico Models for Predicting Acute Systemic Toxicity.Methods in molecular biology (Clifton, N.J.) · 2022Review
- Quinazolin-4(3Journal of enzyme inhibition and medicinal chemistry · 2021Article
- Trends in application of advancing computational approaches in GPCR ligand discovery.Experimental biology and medicine (Maywood, N.J.) · 2021Review
- Structure-activity relationships study of isothiocyanates for HJournal of advanced research · 2021Review
- Cinnamides TargetMolecules (Basel, Switzerland) · 2020Article
- Development of In Vitro Corneal Models: Opportunity for Pharmacological Testing.Methods and protocols · 2020Review
- A Series of Isatin-Hydrazones with Cytotoxic Activity and CDK2 Kinase Inhibitory Activity: A Potential Type II ATP Competitive Inhibitor.Molecules (Basel, Switzerland) · 2020Article
- Computer-Driven Development of an in Silico Tool for Finding Selective Histone Deacetylase 1 Inhibitors.Molecules (Basel, Switzerland) · 2020Article
- Calculation of absolute binding free energies between the hERG channel and structurally diverse drugs.Scientific reports · 2019Article
- Computational Approaches for Drug Discovery.Molecules (Basel, Switzerland) · 2019Article
- Computational determination of hERG-related cardiotoxicity of drug candidates.BMC bioinformatics · 2019Article
- Rescoring and Linearly Combining: A Highly Effective Consensus Strategy for Virtual Screening Campaigns.International journal of molecular sciences · 2019Article
- Deep Learning-Based Prediction of Drug-Induced Cardiotoxicity.Journal of chemical information and modeling · 2019Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The development of a novel comprehensive approach for the prediction of
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.